Oral Anticoagulation Continuation Throughout TAVR: High Risk-High Reward or Marginal Gains?

JACC Cardiovasc Interv. 2021 Jan 25;14(2):145-148. doi: 10.1016/j.jcin.2020.10.026. Epub 2020 Dec 23.
No abstract available

Keywords: atrial fibrillation; bleeding; direct-acting oral anticoagulant; oral anticoagulant; stroke; transcatheter aortic valve replacement.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • Aortic Valve Stenosis* / diagnostic imaging
  • Aortic Valve Stenosis* / drug therapy
  • Aortic Valve Stenosis* / surgery
  • Humans
  • Reward
  • Transcatheter Aortic Valve Replacement* / adverse effects
  • Treatment Outcome
  • Vitamin K

Substances

  • Anticoagulants
  • Vitamin K